| Name | Title | Contact Details |
|---|---|---|
Michael Mainiero |
Senior Vice President and Chief Digital and Information Officer | Profile |
Tim Swope |
Chief Information Security Officer | Profile |
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
Founded in March 2019, the objective of The Fertility Partners (“TFP”) is to be a world class business partner of choice for leading North-American IVF clinicians with the goal of achieving global best clinical outcomes, an international reputation for excellence and exceptional patient experiences. TFP will provide partner clinics with back office support and a collaborative synergistic medical-scientific, professional and business environment.
Elcor Health Svc is a Horseheads, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Moorestown Visiting Nurse Association is a Moorestown, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Female Health Company is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.